AmerisourceBergen Corporation

AmerisourceBergen Corporation, now known as Cencora, is a leading global healthcare solutions company specializing in pharmaceutical distribution and related services.

Established in 2001 through the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation, the company has grown to become one of the largest pharmaceutical distributors worldwide.

Cencora's primary operations include distribution of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment.

The company serves a diverse clientele:

• Acute care hospitals and health systems
• Independent and chain retail pharmacies
• Mail-order facilities and physicians
• Clinics, alternate site facilities
• Nursing and assisted living centers

In addition to distribution, Cencora offers a comprehensive suite of solutions to enhance the healthcare supply chain's efficiency and effectiveness.

These services encompass data analytics, outcomes research, reimbursement and pharmaceutical consulting, logistics services, inventory management, pharmacy automation, pharmacy management, and packaging solutions.

Key Segments

• Pharmaceutical Distribution Services: Focus on drug distribution, strategic global sourcing, reducing healthcare costs, and improving patient outcomes.
• Global Commercialization Services: Provided through AmerisourceBergen Consulting Services (ABCS) and World Courier, offering integrated manufacturer services including clinical trial support and product commercialization.
• Animal Health Solutions: Under MWI Animal Health, supplying pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients to animal markets.
• International Pharmaceutical Wholesale and Related Services: Through Alliance Healthcare, supplying pharmaceuticals and healthcare products to pharmacies, doctors, health centers, and hospitals.

Company Size and Location

Cencora is headquartered in Sugar Land, TX, USA. It employs over 41,000 associates and operates more than 600 locations worldwide.

In the United States, it handles approximately 20% of all pharmaceuticals sold and distributed, reflecting its massive role in the supply chain.

Innovation and Growth

The company's commitment to innovation and customer-centric solutions has been pivotal in maintaining its leadership in healthcare.

Its global footprint continues to expand, exemplified by acquisitions such as Retina Consultants of America to enhance specialty healthcare services.

Cencora's dedication to improving patient care and advancing the healthcare supply chain solidifies its role as a cornerstone of the pharmaceutical industry.